Antiphospholipid syndrome (APS) is an autoimmune disease characterized by venous
thromboembolism, arterial thrombosis, and obstetric morbidities in the setting of persistently …

Antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy
complications in the presence of persistent antiphospholipid antibodies (APLA). Laboratory …

APS is among the most frequent acquired risk factors for a treatable cause of recurrent
pregnancy loss and increases the risk of conditions associated with ischaemic placental …

When should a patient with a known thrombophilia or prior venous thromboembolism (VTE)
receive low-molecular-weight heparin (LMWH) prophylaxis during pregnancy and/or the …

Problem To examine whether the level of plasma D‐dimer can guide anticoagulant
treatment in recurrent pregnancy loss (RPL) associated with antiphospholipid syndrome …

Placenta-mediated pregnancy complications, such as pre-eclampsia, placental abruption,
birth of a small-for-gestational age infant and late pregnancy loss, are common and carry …

The role of anticoagulants in the prevention of pregnancy complications, including recurrent
miscarriage, late fetal loss, and preeclampsia, continues to be an area of active research …

Most investigators currently advocate prophylactic-dose heparin plus low-dose aspirin as
the preferred treatment of otherwise healthy women with obstetric antiphospholipid …

抗磷脂综合征治疗进展 中国实用内科杂志 首页 期刊介绍 编委会 投稿指南 期刊订阅 许可声明 广告合作
联系我们 English 中国实用内科杂志 • 专题笔谈• 上一篇 下一篇 抗磷脂综合征治疗进展 1.中国医学 …

ABSTRACT Background: Recurrent miscarriage affects 1–2% of women. Recurrent
pregnancy loss (RPL) is the loss of three or more consecutive pregnancies before or during …